A longitudinal study of biochemical markers of bone turnover during normal pregnancy and pregnancies complicated by pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 109, Issue 6, 2002, Pages 708-713

  Anim Nyame, N ^a   Sooranna, S R ^a   Jones, J ^b   Alaghband Zadeh, J ^b   Steer, P J ^a   Johnson, M R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN TYPE 1; PEPTIDE; PROTEIN; URIC ACID; BIOLOGICAL MARKER; COLLAGEN; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE I CARBOXY TERMINAL PEPTIDE;

ADULT; ARTICLE; BLOOD SAMPLING; BONE TURNOVER; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; LONGITUDINAL STUDY; MATERNAL PLASMA; OSSIFICATION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE; URIC ACID BLOOD LEVEL; BLOOD; BONE REMODELING; METABOLISM; METHODOLOGY; PHYSIOLOGY; PREGNANCY; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; BONE REMODELING; COLLAGEN; COLLAGEN TYPE I; FEMALE; HUMANS; LONGITUDINAL STUDIES; PEPTIDE FRAGMENTS; PEPTIDES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROCOLLAGEN; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY;

EID: 0036598230     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2002.00353.x     Document Type: Article

References (31)

1. Seely E.W., Wood R.J., Brown E.M., Graves S.W. Lower serum ionised calcium and abnormal calcitrophic hormone levels in pre-eclampsia. J Clin Endocrinol Metab. 74:1992;1436-1440.
2. Pedersen E.B., Johannsen P., Kristensen Set al. Calcium parathyroid hormone and calcitonin in normal pregnancy and pre-eclampsia. Gynecol Obstet Invest. 18(3):1984;156-164.
3. Frenkel Y., Barkai G., Mashiacxh S., Dolev E., Zimlichman R., Weiss M. Hypocalciuria of preeclampsia is independent of parathyroid hormone levels. Obstet Gynecol. 77:1991;689-691.
4. August P., Marcaccio B., Gertner J.M., Druzin M.L., Resnick L.M., Laragh J.H. Abnormal 1,25 hydroxyvitamin D metabolism in pre-eclampsia. Am J Obstet Gynecol. 166:1992;1295-1299.
5. Tolaymat A., Sanchez-Ramos L., Yergey A.L., Viera N.E., Abrams S.A., Edelstein P. Pathophysiology of hypocalciuria in pre-eclampsia: measurement of intestinal calcium absorption. Obstet Gynecol. 83:1994;239-243.
6. Anim-Nyame N., Sooranna S.R., Jones J., Alghband-Zadeh J., Steer P.J., Johnson M.R. Bone metabolism is increased in pre-eclampsia. Br J Obstet Gynaecol. 108:2001;258-262.
7. Eriksen E.F., Charles P., Melsen F., Moseklide L., Risteli J. Serum markers of type I collagen formation and degradation: correlation to bone histomorphometry. J Bone Miner Res. 8:1993;127-132.
8. Melkko J., Niemi S., Risteli J. Radioimmunoassay of the carboxy terminal propeptide of human type I procollagen. Clin Chem. 36:1990;1328-1332.
9. Report on the National High Blood Pressure Educational Programme Working group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 183(1):2000;S1-S22.
10. Watanabe N., Kamel S., Ohkubo A., Yamanaka M., Ohsawa S., Makino K. Urinary protein as measured with pyrogallol red-molybdate complex manually and in Hitachi 726 automated analyser. Clin Chem. 32:1986;1551-1554.
11. Matthews J.N.S., Altman D.G., Campbell M.J., Royston J.P. Analysis of serial measurements in medical research. BMJ. 300:1990;230-235.
12. Morikawa H., Cough S.Y., Ohara Net al. Pregnancy-induced hypertension and osteoporosis. Nippon Naibunpi Gakkai zasshi. 65(10):1989;1123-1124.
13. Jones O.V. Crush fracture of the dorsal spine in eclampsia. J Obstet Gynaecol Br Emp. 60:1953;259-262.
14. Roberts J.M., Redman C.W.G. Pre-eclampsia: more than pregnancy induced hypertension. Lancet. 341:1993;1447-1451.
15. Hubel C.A. Oxidative stress and pre-eclampsia. Fetal Matern Med Rev. 9:1997;73-101.
16. Greer I.A., Lyall F., Pepera T., Boswell F., Macara L.M. Increased concentrations of cytokine-6 and interleukin-1 receptor antagonist in plasma of women with pre-eclampsia: a mechanism for endothelial dysfunction. Obstet Gynecol. 84:1994;937-940.
17. Giudice L.C., Martina N.A., Crystal R.A., Tazuke S., Druzin M.I. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-1 in the circulation of women with severe pre-eclampsia. Am J Obstet Gynecol. 176(4):1997;751-757.
18. Gosiewska A., Wilson S., Kwon D., Peterkofsky B. Evidence for an in vivo role of insulin-like growth factor-binding protein-1 and -2 as inhibitors of collagen gene expression in vitamin C-deficient and fasted guinea pigs. Endocrinology. 134(3):1994;1329-1339.
19. Garrett R., Boyce B.F., Oreffo R.O.C., Bonewald L., Poser J., Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest. 85(3):1990;632-639.
20. Roodman G.D. Role of cytokines in the regulation of bone resorption. Calcif Tissue Int. 53(Suppl 1):1993;S94-S98.
21. Collin-Osdoby P. Role of vascular endothelial cells in bone biology. J Cell Biochem. 55(3):1994;304-309.
22. Redman C.W., Sacks G.P., Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 180:1999;499-506.
23. Puistola U., Risteli L., Kauppilla A., Knip M., Ristela J. Markers of Type I and Type III collagen synthesis in serum as indicators of tissue growth during pregnancy. J Clin Endocrinol Metab. 77:1993;178-182.
24. Ross P.D., Knowlton W. Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res. 13:1998;297-302.
25. Chesnut C.H. III, Bell N.H., Clark GSet al. Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med. 102:1997;29-37.
26. Cappuccio F.P., Meihlan E., Zmuda J.M., Cauley J.A. High blood pressure and bone mineral loss in elderly white women: a prospective study. Lancet. 354:1999;971-975.
27. McCarron D.A., Pingree P.A., Rubin R.J., Gaucher S.M., Molitch M., Krutzik S. Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension. 2(2):1980;162-168.
28. Suarez V.R., Miyahira J.M., Guinn D.A., Fisher S.G., Tomich P.G., Trelles J.G. Calciuria in symptom free primigravid women remote from term: is the response to oral calcium challenge predictable? Am J Obstet Gynecol. 180:1999;1419-1421.
29. Watts N.B. Clinical utility of biochemical markers of bone remodelling. Clin Chem. 45:1999;1359-1368.
30. Risteli J., Melkko J., Niemi S., Risteli L. Use of a marker of collagen formation in osteoporosis studies. Calcif Tissue Int. 49(Suppl):1991;S24-S25.
31. Eisman J. The relevance of pregnancy and lactation to osteoporosis. Lancet. 352:1998;504-505.